Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -13569.60x is 67% above its 4-year average of -40603.81x, near the high end of its 4-year range (-182977.00x–-1219.64x).
As of the fiscal period ended Monday, May 31, 2021. 23.20% below its 12-month average of -11013.99x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2021 (2021-05-31): -13569.60x.
INTEREST COVERAGE RATIO
-13569.60x
INTEREST COVERAGE RATIO AVG TTM
-11013.99x
INTEREST COVERAGE RATIO AVG 3Y
-62525.98x
INTEREST COVERAGE RATIO AVG 5Y
-40603.81x
INTEREST COVERAGE RATIO AVG 10Y
-3927.70x
INTEREST COVERAGE RATIO AVG 15Y
-1598.96x
INTEREST COVERAGE RATIO AVG 20Y
-501.35x
CURRENT VS TTM AVG
-23.20%
CURRENT VS 3Y AVG
+78.30%
CURRENT VS 5Y AVG
+66.58%
CURRENT VS 10Y AVG
-245.49%
CURRENT VS 15Y AVG
-748.65%
CURRENT VS 20Y AVG
-2606.61%
SECTOR MEDIAN · HEALTHCARE
-3.05x
median of 299 covered companies
CURRENT VS SECTOR MEDIAN
-444805.04%
vs the sector median at left
Biomerica, Inc.
Market Cap
$6.34M
Interest Coverage Ratio
-13569.60x
TTM Avg
-11013.99x
3Y Avg
-62525.98x
5Y Avg
-40603.81x
Market Cap
$6.44M
Interest Coverage Ratio
-545.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.10M
Interest Coverage Ratio
-438.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.09M
Interest Coverage Ratio
-1153.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.03M
Interest Coverage Ratio
-310.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.76M
Interest Coverage Ratio
-82777.81x
TTM Avg
11.97x
3Y Avg
11.97x
5Y Avg
11.97x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomerica, Inc. (BMRA) | $6.34M | -13569.60x | -11013.99x | -62525.98x | -40603.81x |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | -545.69x | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.10M | -9.30x | N/A | N/A | N/A |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -438.08x | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | -1153.85x | N/A | N/A | N/A |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | -310.21x | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | N/A | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.74M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | -82777.81x | 11.97x | 11.97x | 11.97x |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | N/A | N/A | N/A | N/A |
Interest Coverage
-13569.6x
Debt/Equity
0.72
Current Ratio
1.62
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-05-31 | -13569.60x |
| 2021-02-28 | -8458.38x |
| 2020-02-29 | -182977.00x |
| 2019-11-30 | -97948.60x |
| 2018-08-31 | -9676.30x |
| 2017-11-30 | -7803.73x |
| 2017-02-28 | -3177.22x |
| 2016-11-30 | -1219.64x |
| 2016-02-29 | -3900.12x |
| 2015-11-30 | -11654.11x |
| 2015-08-31 | -2117.58x |
| 2014-08-31 | -12450.61x |
| 2014-05-31 | -935.42x |
| 2014-02-28 | 1630.85x |
| 2012-08-31 | 1013.48x |
| 2012-05-31 | 126.10x |
| 2012-02-29 | 786.51x |
| 2011-11-30 | 524.56x |
| 2011-08-31 | 204.02x |
| 2011-07-29 | -21.31x |
| 2011-02-28 | 54.29x |
| 2010-11-30 | -109.30x |
| 2010-08-31 | -5.73x |
| 2010-05-31 | -78.38x |
| 2010-02-28 | 38.66x |
| 2009-11-30 | -83.30x |
| 2009-08-31 | 1.37x |
| 2009-05-31 | -1.26x |
| 2009-02-28 | 43.13x |
| 2008-02-29 | 9.49x |
| 2007-08-31 | 17.09x |
| 2007-05-31 | 21.38x |
| 2004-11-30 | -13.39x |
| 2004-02-29 | 11.19x |
| 2003-11-30 | -26.28x |
| 2003-08-31 | -29.74x |
| 2003-02-28 | -0.22x |
